Single-Use Bioprocessing Market to Surpass $26.54 Billion by 2028 - Arizton

Arizton publishes the latest research report, Single-use Bioprocessing Market - Global Outlook & Forecast 2023-2028. The global single-use bioprocessing market to reach USD 26.54 billion by 2028, growing at a CAGR of 19.74%. 
 
The report provides an in-depth analysis of the present scenario of the global single-use bioprocessing market and its market dynamics from 2023 to 2028. It comprehensively overviews various factors that drive market growth, restraints, and trends. Both the demand and supply aspects of the industry are thoroughly examined. Furthermore, the report includes profiles and evaluations of major companies and several other prominent players operating within the sector. 

To Know More, Download the Free Sample Report: https://www.arizton.com/request-sample/3887 

The global single-use bioprocessing market has grown significantly in the upcoming years. New product launches enabling single-use technology adoption are a great way to reduce waste and improve sustainability. Single-use technology allows companies to reduce their reliance on disposable products and materials while still providing customers with quality products. This technology can be used to create more efficient and sustainable packaging and products that are easier to use and more cost-effective. In addition, single-use technology can help reduce the environmental impact of production and consumption and the amount of waste generated. With the launch of new products that enable the adoption of single-use technology, companies can positively impact the environment and create a more sustainable future. 

Expansion of Healthcare Sector and Growing Biologics Market Propelling the APAC Single-Use Bioprocessing Industry  

APAC offers tremendous growth potential for global vendors due to the expanding healthcare sector and increased public and private spending. Moreover, major manufacturing facilities for biosimilars are being established in this region due to the high demand for biosimilars. Moreover, CMOs have strengthened their presence in this region due to global players' increasing outsourcing of manufacturing activities. Therefore, vendors have invested in and expanded their businesses in this region.  

The penetration of biologics has increased significantly in the growing APAC pharma industry due to the introduction of new biologics and their increased adoption. Moreover, the high uptake of biosimilars has contributed to the market growth of the global biopharmaceuticals market, which, in turn, has driven the single-use bioprocessing market in APAC. The market for biologics, such as vaccines, stem cells, mAbs, and biosimilars manufactured using bioprocessing methods, has grown faster than the rest of the pharma drugs market in this region over the past few years. This will impact the market growth of single-use bioprocessing in APAC positively.  

Competitive Overview 

Growing interest and high demand from major biopharmaceutical companies for SUTs have encouraged vendors to undertake several business strategies to maintain a competitive edge over their competitors in the market. These strategies include acquiring emerging/small, specialized single-use suppliers, product portfolio development, regional market expansion, and global distribution network strengthening. For instance, major vendors have acquired local/regional and emerging companies involved in disposables manufacturing, supporting the adoption and integration of single-use bioreactors and other capital-intensive equipment. Vendors have also made huge investments to expand their existing single-use product portfolios to gain traction and expand their presence in the market.   

Key Company Profiles 

Thermo Fisher Scientific 

Sartorius Stedim Biotech 

Danaher 

Merck KGaA 

Avantor 

3i Group 

3M 

ABEC 

Adolf Kühner 

AdvantaPure 

Barry-Wehmiller Companies 

Broadley-James 

Celltainer Biotech 

CerCell A/S 

CESCO Bioengineering 

Charter Medical 

Colder Products Company 

Corning 

Distek 

DrM, Dr. Mueller 

Emerson Electric 

Entegris 

Eppendorf 

Foxx Life Sciences 

Getinge 

HIGH PURITY NEW ENGLAND 

Holland Applied Technologies 

Lonza 

MEISSNER FILTRATION PRODUCTS 

New Horizon Biotech 

OmniBRx Biotechnologies 

PARKER HANNIFIN 

PendoTECH 

PBS Biotech 

Repligen 

Saint-Gobain 

Sentinel Process Systems 

Solaris Biotechnology 

SYSBIOTECH GmbH 

Watson-Marlow Fluid Technology Solutions 

Weigao Group 

W.L. Gore & Associates 

Market Segmentation 

Product Type: Single-use Bioprocessing Equipment and Simple & Peripheral Devices 

Application: Monoclonal Antibodies (mABs), Vaccines, Cell Therapies, and Others 

End-users: Biopharmaceutical Manufacturers, Contract Manufacturing Organizations (CMOs), and R&D Companies & Research Institutes 

Method: Filtration, Storage & Transport, Cell Culture, Mixing, and Purification 

Workflow: Upstream and Downstream 

Geography: North America, Europe, APAC, Latin America, and Middle East & Africa 

Key Questions Answered in the Report:    
How big is the global single-use bioprocessing market? 
What is the growth rate of the single-use bioprocessing market? 
What are the rising trends in the single-use bioprocessing market? 
Which region holds the most significant global single-use bioprocessing market share? 
Who are the key players in the global single-use bioprocessing market? 

Check Out Some of the Top Selling Research Reports:      

Biopharmaceutical Contract Manufacturing Market - Global Outlook & Forecast 2022-2027 
https://www.arizton.com/market-reports/biopharmaceutical-contract-manufacturing-market 

Single-Use Bioprocessing Probes and Sensors Market - Global Outlook & Forecast 2022-2027 
https://www.arizton.com/market-reports/single-use-bioprocessing-probes-and-sensors-market 

Vaccine Contract Manufacturing Market - Global Outlook and Forecast 2021-2026 
https://www.arizton.com/market-reports/vaccine-contract-manufacturing-market 

Surgical Wound Closure Devices Market - Global Outlook and Forecast 2021-2026 
https://www.arizton.com/market-reports/surgical-wound-closure-devices-market-size-analysis 

Check the detailed table of contents of the report @ https://www.arizton.com/market-reports/single-use-bioprocessing-market?details=tableOfContents 

Why Arizton?      
100% Customer Satisfaction      
24x7 availability - we are always there when you need us      
200+ Fortune 500 Companies trust Arizton's report      
80% of our reports are exclusive and first in the industry      
100% more data and analysis      
1500+ reports published till date      

About Us:                                           
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.                                         

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.                                          

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.  

Contact Us                                        
Call: +1-312-235-2040                                       
          +1 302 469 0707                                      
Mail: enquiry@arizton.com                                        
Contact Us: https://www.arizton.com/contact-us                                        
Blog: https://www.arizton.com/blog                                        
Website: https://www.arizton.com/                 

This release was published on openPR.